Quick-Med Technologies Stock

Quick-Med Technologies EBITDA per Share

The EBITDA per Share of Quick-Med Technologies (QMDT) as of Aug 21, 2026 is -0.01 USD.

EBITDA per Share

-0.01USD

Last updated:

EBITDA per Share of Quick-Med Technologies is 2026 -0.01 USD. EBITDA per Share of Quick-Med Technologies was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Quick-Med Technologies Stock analysis

What does Quick-Med Technologies do? Quick-Med Technologies Inc is a US company based in Gainesville, Florida, specializing in medical technologies. The company was founded in 1994 by Dr. Robert Banas and Dr. John Kosinski to develop a solution to the increasing problem of multidrug-resistant bacteria in hospitals. Quick-Med Technologies' business model is based on the development and marketing of antimicrobial products for infection prevention. This includes wound dressings, textiles, and sprays equipped with a special technology to inhibit the growth of bacteria and fungi. The company works closely with customers in the healthcare, textile, and aviation industries to utilize its products in various applications. The growing demand for antimicrobial solutions and the increasing global threat of infections have made Quick-Med Technologies an important player in the market in recent years. The company specializes in four core areas: medical products, textiles, aviation, and veterinary medicine. In the medical products sector, Quick-Med Technologies offers innovative wound dressings with effective bacteriostatic properties. The dressings are well-tolerated and are particularly effective against multidrug-resistant bacteria. Additionally, there are special products for infection prevention, especially used in hospitals. The second sector, textiles, includes special anti-infection coating capabilities to equip textiles against mold, bacteria, and fungi. The company offers customers from the textile and apparel industry a variety of antimicrobial coated fabrics, which are also used in the hospitality, gastronomy, and public facilities sectors. These include bedding, towels, uniforms, and carpets, for example. In the aviation industry, antimicrobial coatings are used in aircraft cabins and other means of transportation to prevent infections. Quick-Med Technologies offers special disinfectants and sprays for effective cleaning and disinfection of surfaces. The company's fourth business area is veterinary medicine, where Quick-Med Technologies develops innovative solutions for disinfection and wound healing in animals. The company's products are used in both pet medicine and livestock farming and have proven to be effective against infections. Quick-Med Technologies has shown strong growth in recent years and has received a number of patents for its technology. The company also actively engages in research and development of new antimicrobial solutions and collaborates closely with industry and scientific partners. Overall, Quick-Med Technologies is an innovative company specializing in fighting infections and improving hygiene. The company's antimicrobial products help reduce the spread of bacteria and fungi in various applications, minimizing the risk of infections. Quick-Med Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quick-Med Technologies stock

EBITDA per Share of Quick-Med Technologies is -0.01 USD in 2026.

On Eulerpool you can find the complete historical development of EBITDA per Share Quick-Med Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Quick-Med Technologies

All Key Metrics — Quick-Med Technologies